F Rahman1, S J Seung2, S Y Cheng1, H Saherawala2, C C Earle1, N Mittmann3. 1. Institute for Clinical Evaluative Sciences, ON. 2. Health Outcomes and Pharmacoeconomics ( hope ) Research Centre, Sunnybrook Research Institute, ON. 3. Cancer Care Ontario, ON.; University of Toronto, ON.; Sunnybrook Research Institute, Toronto, ON.
Abstract
OBJECTIVE: Costs for radiation therapy (rt) and the methods used to cost rt are highly diverse across the literature. To date, no study has compared various costing methods in detail. Our objective was to perform a thorough review of the radiation costing literature to identify sources of costs and methods used. METHODS: A systematic review of Ovid medline, Ovid oldmedline, embase, Ovid HealthStar, and EconLit from 2005 to 23 March 2015 used search terms such as "radiation," "radiotherapy," "neoplasm," "cost," " cost analysis," and "cost benefit analysis" to locate relevant articles. Original papers were reviewed for detailed costing methods. Cost sources and methods were extracted for papers investigating rt modalities, including three-dimensional conformal rt (3D-crt), intensity-modulated rt (imrt), stereotactic body rt (sbrt), and brachytherapy (bt). All costs were translated into 2014 U.S. dollars. RESULTS: Most of the studies (91%) reported in the 33 articles retrieved provided rt costs from the health system perspective. The cost of rt ranged from US$2,687.87 to US$111,900.60 per treatment for imrt, followed by US$5,583.28 to US$90,055 for 3D-crt, US$10,544.22 to US$78,667.40 for bt, and US$6,520.58 to US$19,602.68 for sbrt. Cost drivers were professional or personnel costs and the cost of rt treatment. Most studies did not address the cost of rt equipment (85%) and institutional or facility costs (66%). CONCLUSIONS: Costing methods and sources were widely variable across studies, highlighting the need for consistency in the reporting of rt costs. More work to promote comparability and consistency across studies is needed.
OBJECTIVE: Costs for radiation therapy (rt) and the methods used to cost rt are highly diverse across the literature. To date, no study has compared various costing methods in detail. Our objective was to perform a thorough review of the radiation costing literature to identify sources of costs and methods used. METHODS: A systematic review of Ovid medline, Ovid oldmedline, embase, Ovid HealthStar, and EconLit from 2005 to 23 March 2015 used search terms such as "radiation," "radiotherapy," "neoplasm," "cost," " cost analysis," and "cost benefit analysis" to locate relevant articles. Original papers were reviewed for detailed costing methods. Cost sources and methods were extracted for papers investigating rt modalities, including three-dimensional conformal rt (3D-crt), intensity-modulated rt (imrt), stereotactic body rt (sbrt), and brachytherapy (bt). All costs were translated into 2014 U.S. dollars. RESULTS: Most of the studies (91%) reported in the 33 articles retrieved provided rt costs from the health system perspective. The cost of rt ranged from US$2,687.87 to US$111,900.60 per treatment for imrt, followed by US$5,583.28 to US$90,055 for 3D-crt, US$10,544.22 to US$78,667.40 for bt, and US$6,520.58 to US$19,602.68 for sbrt. Cost drivers were professional or personnel costs and the cost of rt treatment. Most studies did not address the cost of rt equipment (85%) and institutional or facility costs (66%). CONCLUSIONS: Costing methods and sources were widely variable across studies, highlighting the need for consistency in the reporting of rt costs. More work to promote comparability and consistency across studies is needed.
Authors: Ahmed Eldefrawy; Devendar Katkoori; Matthew Abramowitz; Mark S Soloway; Murugesan Manoharan Journal: Urol Oncol Date: 2011-05-25 Impact factor: 3.498
Authors: Bram L T Ramaekers; Janneke P C Grutters; Madelon Pijls-Johannesma; Philippe Lambin; Manuela A Joore; Johannes A Langendijk Journal: Int J Radiat Oncol Biol Phys Date: 2012-12-27 Impact factor: 7.038
Authors: Anthony J Paravati; Isabel J Boero; Daniel P Triplett; Lindsay Hwang; Rayna K Matsuno; Beibei Xu; Loren K Mell; James D Murphy Journal: J Oncol Pract Date: 2015-08-11 Impact factor: 3.840
Authors: Racquel E Kohler; Nathan C Sheets; Stephanie B Wheeler; Chris Nutting; Emma Hall; Bhishamjit S Chera Journal: Int J Radiat Oncol Biol Phys Date: 2013-11-15 Impact factor: 7.038
Authors: N Mittmann; S Y Cheng; N Liu; S J Seung; F E Saxena; C DeAngelis; N J Look Hong; C C Earle; M C Cheung; N Leighl; N Coburn; W K Evans Journal: Curr Oncol Date: 2019-10-01 Impact factor: 3.677
Authors: Nicole Mittmann; Ning Liu; Stephanie Y Cheng; Soo Jin Seung; Farah E Saxena; Nicole J Look Hong; Craig C Earle; Matthew C Cheung; Natasha B Leighl; Natalie G Coburn; Carlo DeAngelis; William K Evans Journal: CMAJ Open Date: 2020-03-16
Authors: Paulien G Westhoff; Alexander de Graeff; Evelyn M Monninkhof; Ilse de Pree; Marco van Vulpen; Jan Willem H Leer; Corrie A M Marijnen; Yvette M van der Linden Journal: J Radiat Oncol Date: 2017-09-19